Sagimet Biosciences (SGMT) Cash from Financing Activities (2022 - 2025)
Sagimet Biosciences' (SGMT) quarterly Cash from Financing Activities came in at $274000.0 in Q3 2025, up 1114.81% quarter-over-quarter from -$27000.0 in Q2 2024.
Sagimet Biosciences (SGMT) Cash from Financing Activities (2022 - 2025) Analysis & Trends
Sagimet Biosciences' Cash from Financing Activities history runs 4 years deep, the most recent figure standing at $274000.0 for Q3 2025.
- On a quarterly basis, Cash from Financing Activities changed N/A year-over-year to $274000.0 in Q3 2025; TTM through Dec 2025 was $274000.0, a 99.74% decrease from a year earlier, with the FY2025 full-year figure at $275000.0, down 99.74% from the prior year.
- Cash from Financing Activities rose to $274000.0 in Q3 2025 per SGMT's latest filing, from -$27000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $104.8 million in Q1 2024 and bottomed at -$910000.0 in Q2 2023.
- The 4-year median for Cash from Financing Activities is -$27000.0 (2024), against an average of $27.3 million.
- Biggest YoY gain for Cash from Financing Activities was 77192.65% in 2024; the steepest drop was 97.03% in 2024.
- Year by year, Cash from Financing Activities stood at -$55000.0 in 2022, then jumped by 158669.09% to $87.2 million in 2023, then tumbled by 100.03% to -$27000.0 in 2024, then soared by 1114.81% to $274000.0 in 2025.
- Per Business Quant, the three latest SGMT Cash from Financing Activities figures stand at $274000.0 (Q3 2025), -$27000.0 (Q2 2024), and $104.8 million (Q1 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 30.14 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 53,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 68.63 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -538.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -802.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 238.74 Mn |
| 10 | Sagimet Biosciences | 227.27 Mn | 227.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 274,000.00 |
| Sep 30, 2025 | 274,000.00 |
| Jun 30, 2024 | -27,000.00 |
| Jun 30, 2024 | -27,000.00 |
| Mar 31, 2024 | 104.85 Mn |
| Mar 31, 2024 | 104.85 Mn |
| Sep 30, 2023 | 87.21 Mn |
| Sep 30, 2023 | 87.21 Mn |
| Jun 30, 2023 | -910,000.00 |
| Jun 30, 2023 | -910,000.00 |
| Mar 31, 2023 | -136,000.00 |
| Mar 31, 2023 | -136,000.00 |
| Dec 31, 2022 | -55,000.00 |
| Dec 31, 2022 | -55,000.00 |